Recent Finacing
Recent Raise
PrEP Biopharm is a development-stage biopharmaceutical company developing PrEP-001, a nasally administered innate-immune, broad-spectrum agent to prevent upper respiratory viral infections, based on Janssen-licensed IP.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors